This year at ISPOR 2021 Virtual, Broadstreet and our friends at Avalon Health Economics will be facilitating a workshop about how public health data can feed into valuations of COVID-19 interventions. The session: Lost in Transmission: Analytic Applications of Public Health Data to Inform Evaluations of the Efficacy, Effectiveness, and Value of Interventions for COVID-19 will be held on May 18, 2021 from 1:45 PM – 2:45 PM EST. Come join us, as it’s sure to be an interesting conversation. You can also check out this app we made that compiles public health data on COVID by jurisdiction and calculates a real-time approximation of the basic reproduction number.

During the conference, we will also be sharing a poster comparing two methods for calculating the reproduction number for COVID-19, as well as a giving a presentation on the drivers of health state utilities in Duchenne muscular dystrophy. In addition, we will have a number of posters presenting the findings of research projects we have been involved in recently.

We hope you will stop by (virtually) and have a look.

WORKSHOP

Lost in Transmission: Analytic Applications of Public Health Data to Inform Evaluations of the Efficacy, Effectiveness, and Value of Interventions for COVID-19

Discussion Leaders: John Schneider, PhD, Avalon Health Economics, Morristown, NJ, USA; Scott Emerson, MSc, Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada; Karissa M Johnston, PhD, Memorial University, Vancouver, BC, Canada; Shelagh Szabo, MSc, Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada

Breakout session 2
Tuesday, May 18, 2021
1:45 pm to 2:45 pm

PRESENTATION

The drivers of health state utilities in Duchenne muscular dystrophy (DMD): a study using the health utilities index mark 3 (HUI3) Rogula B, ¹ Audhya I, ² Szabo SM, ¹ Feeny D, ³ Bolatova T, ¹ Gooch KL²¹

Broadstreet HEOR, Vancouver BC Canada; ²Sarepta Therapeutics, Cambridge MA, USA; ³McMaster University and Health Utilities Inc, Hamilton, ON Canada SC3 – available in pre-release under in the Mixed Diseases and Conditions Studies section

POSTERS

Leveraging Publicly Available Data to Estimate a Real-Time Reproduction Number (Rt) for Covid-19: A Comparison of Two Methods Emerson S, ¹ Johnston K, ² Howarth A, ³ Schneider J, ³ Friesen M, ¹ Szabo S¹

¹Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada; ²Memorial University, Vancouver, BC, Canada; ³Avalon Health Economics, Morristown, NJ, USA

Challenges in the estimation of birth prevalence for rare diseases: a case study
Osenenko KM¹, Deighton AM¹, Szabo SM¹

¹Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada

ENCORE POSTERS

BoNT-As for Adult Spasticity and Cervical Dystonia: Cost-Effectiveness Analysis and the Cost of Response in the United Kingdom Johnston KM,¹ Danchenko N,² Bolatova T,¹ Whalen J³ P

reviously presented at Toxins, 2020

Cost-Effectiveness of BoNT-A Products for Treatment of Pediatric Spasticity in the United Kingdom
Danchenko N,¹ Johnston KM,² Bolatova T,² Whalen J³

¹Ipsen Global, Boulogne-Billancourt, France; ²Broadstreet Health Economics and Outcomes Research, Vancouver, Canada; ³Ipsen Biopharm Ltd, Slough, UK

Previously presented at Toxins, 2020